The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Population pharmacokinetic (PopPK) and exposure-response (ER) modeling of cabozantinib (C) in patients (pts) with renal cell carcinoma (RCC) in the phase 3 METEOR study.
 
Steven Lacy
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Matthew M Hutmacher
No Relationships to Disclose
 
Bei Yang
Consulting or Advisory Role - Exelixis
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Bernard J. Escudier
Honoraria - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Thomas Powles
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis
Research Funding - Exelixis; Genentech; GlaxoSmithKline; Novartis
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Dale Miles
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Jace Nielsen
Consulting or Advisory Role - Exelixis